Intelligent Bio Solutions Inc (INBS)

[glenn1919]

INBS............................https://stockcharts.com/h-sc/ui?s=INBS&p=W&b=5&g=0&id=p86431144783

[glenn1919]

INBS.........................................................................https://stockcharts.com/h-sc/ui?s=INBS&p=W&b=5&g=0&id=p86431144783

[Mr Stock pick]

Earnings this week or next
Short squeeze

[Mr Stock pick]

ZERO shares available to short, no where but up from here

[The Night Stalker]

epic weekly

[glenn1919]

INBS................................https://stockcharts.com/h-sc/ui?s=INBS&p=W&b=5&g=0&id=p86431144783

[Mr Stock pick]

Hmm a dead board for such a hot stock… where is everybody ? This is about to explode

[Mr Stock pick]

Low float, 10% short interest, less than a 1000 shares available to short, good news on adding customers and soon good news about FDA approval (more likely to get approved than not) and this will explode with a short squeeze as well

[glenn1919]

INBS....................https://stockcharts.com/h-sc/ui?s=INBS&p=W&b=5&g=0&id=p86431144783

[timberwolf7]

Nov 7th the decision day if my notes are correct.

Chart is hinting that its time for an 'uptick' in the share price

Bit difficult to get a read on its earnings potential, so might play the timeline between
today and Nov 7th, see if it 'gives' a gift..

[timberwolf7]

So whats the prognosis for INBS?? Got their pending FDA decision day
approaching. Only 4 Mil shares, <$8 Mil market cap.. making inroads
overseas.
Question is, will companies here in the US still be ALLOWED to drug
test their employees or if they do, will they charged with 'an invasion of
privacy' or some other BS? For in todays world, our corrupted US labor dept
seems hell bent on giving all the 'power' to the 'people', and is willing to tell
companies how they WILL run their business (or else)
And see a 'target price' of $12/sh on INBS tho no insight t o the
rationale for how this was developed..

Disclaimer: do own a little bit as of yesterday, like that the chart is
hinting at an upturn.. Would load up, but gotten hard to trust the
fda's 'decision' making.. and not demand INBS do a more 'robust' or
whatever trial..

[glens0]

$INBS Somebody bought a lot of shares at day end yesterday. 2 buys after hours 11,956 & 74,984
Here's the post, "https://stocktwits.com/IT_bull/message/587187583

[peterus]

sorry was for Helter

[work-n-hard]

I'm not sure what post you are referencing, but I played this one several times a week or so ago, but haven't been in it since the 19th.

[peterus]

thought you bought 1.69s lol

[work-n-hard]

Thanks. Not in at the moment, but will watch. GLTU

[glens0]

INBS News,
Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that Thanet Earth, the UK’s largest greenhouse complex, has adopted its Intelligent Fingerprinting Drug Screening System for in-house drug testing.
“We are thrilled to partner with Intelligent Fingerprinting to enhance our approach to workplace safety,” said Emma Bullock, Head of People at Thanet Earth. “Fingerprint drug testing allows us to ensure that our team is operating in a safe and efficient manner without interrupting our daily operations.”

Thanet Earth is a leader in the UK’s horticultural sector, producing millions of tomatoes, cucumbers, and peppers annually for major retailers nationwide. The company is renowned for its state-of-the-art approach to sustainable farming, integrating cutting-edge technology to optimize yield and environmental impact.

With the implementation of the Intelligent Fingerprinting Drug Screening System, Thanet Earth will be able to conduct workplace drug testing quickly, discreetly, and effectively. This capability is crucial in maintaining safety within the high-paced food production environment, where even minor disruptions can have significant downstream effects.

[work-n-hard]

INBS: pushing $3M and company touted 10-K this week. (Yr. ending 06-24) Plus watching for competed plan for clinical trial announcement.

[work-n-hard]

Heading much higher today, even without news/filing.

[TIMGZ]

BOLLINGER BAND IS THE STRICTEST, VERSATILE INDICATOR ESPECIALLY FOR WHALES.

https://www.google.com/search?q=BOLLINGER+BAND&sourceid=chrome&ie=UTF-8

[glenn1919]

INBS.............................https://stockcharts.com/h-sc/ui?s=INBS&p=W&b=5&g=0&id=p86431144783

[Helter Skelter]

Tanking some now (@1.69), be looking for a "decent entry" point...no fear of a(n) RS JMO
Grabbed a starter down here...may get out if there's a good bounce otherwise longish...

[Helter Skelter]

As of May 6, 2024, there were 3,117,049 shares of the registrant’s Common Stock issued and outstanding.

Cash & Equivs $9.4M with a quarterly Burn Rate (loss) of approx $2.5M per Q. They may have to have another offering before they receive, hopefully soon, FDA Clearance to market & sell...looks like a pretty safe long (in & out as it goes) play, very interesting product JMO 😺

$INBS FINS as of March 31, 2024:

[Helter Skelter]

Thought their FINS were released today but apparently not. Started DDing this puppy and their product looks quite interesting...

Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering innovative, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. Additionally, the Company’s biosensor platform has the potential to test for various indications, ranging from immunological conditions to communicable diseases. The Company’s current customer segments include construction, manufacturing and engineering, transport and logistics firms, drug treatment organizations, and coroners.?
For more information, visit:?http://www.ibs.inc/

$INBS

Invest, barefoot, crossing the rubicon, lol...

[Invest-in-America]

Complex & difficult stuff, but BEST of luck to ya!!

[Helter Skelter]

Spot on, Invest... after the SEC cleaned-up the OTC, & thereby left no alternative except for the NASDAQ itself to become increasingly CORRUPT!! (Funny stuff, except when one gets SUCKERED by these daily GAP-&-DROPPERS!!)...after the OTC died came over to the NASDAQ and got fooled a few times by the brazen p&ders...in & out...I don't care what it is...however, I do have a shit ton of bookmarkers (stocks with small investment dollars in them)...can't go heavy long until well into 2025...if then even...

[Helter Skelter]

Not saying this isn't a good play, I'll post the FINS in a few minutes. Heavy volume...



$INBS

[Invest-in-America]

Hey, on that note, I remember when iHub's "MONSTA-GAINS" & "CHIVITO" --- remember those fellows(??) --- made your identical observations YEARS ago now, after the SEC cleaned-up the OTC, & thereby left no alternative except for the NASDAQ itself to become increasingly CORRUPT!! (Funny stuff, except when one gets SUCKERED by these daily GAP-&-DROPPERS!!)

[Helter Skelter]

Absolutely, friend, more P&Ds on NASDAQ, nowadays, than the OTC in it's prime...

[Invest-in-America]

YEP!! (Always the way to do it, Bro --- especially THESE days!!)

[Helter Skelter]

😺 In & out, Invest, I know I don't have to remind you of that, GLTY...

[Invest-in-America]

INBS: Behind Benzinga's Pre-Market, & YOUR alert, I still have a cheap $1000-Lotto-Ticket here. (But I already scalped nicely on @SMMT earlier today --- monster NO-BRAINER behind THAT one, Admiral H-S!!)

PS: And THANKS for that DD behind Mr. J. Caesar!!

[Helter Skelter]

InvestAmerica has crossed the Rubicon a few times, lol...

Are you INBS? Lol...



$INBS

[Helter Skelter]

Lol, sorry, not a tool, just going from aft and premarkert into the regular market, the Rubicon, point of no return...a lot of these p&d pOps like to do it in the dead of night under cover of dark...these ihub charts (classic) illuminate the activity...but ya gotta screen capture the activity...





$INBS

[Awl416]

Intelligent Bio Solutions Inc. Announces Preliminary Full Fiscal Year 2024 Revenue Growth of 148% Year-Over-Year

[Invest-in-America]

INBS: And Caesar had the 'GAUL' to do that, Bro!! (All puns intended.)

[reena969]

Helter Skelter, I'm not familiar with your Rubicon indicator, but it definitely caught my attention. I'm always open to exploring new tools to add to my trading arsenal. However, my A.I seems a bit uncertain about it...... She's called " Bestie"

"The Rubicon Trading Indicator doesn't seem to be a well-known, widely referenced tool in mainstream technical analysis literature or trading platforms. It could refer to a proprietary or custom indicator used by specific traders or groups, or it might be a lesser-known tool in a particular trading community."

[Helter Skelter]

$INBS +62% @ 2.56, see chart. All action has been in after and pre markets.

See how this crosses the rubicon...

[Invest-in-America]

INBS, Intelligent Bio Systems (3-Mil. Flt.): $1.58, 21%; (post-M) 30%; recent news seeks FDA o.k. for initial study fast finger-print-sweat Opiod tests, etc.; all things fast med. testing patients, suspects, diseases, drunk, etc.; New York.

[glenn1919]

INBS................................https://stockcharts.com/h-sc/ui?s=INBS&p=W&b=5&g=0&id=p86431144783

[Monksdream]

INBS new 52 week low

[Monksdream]

INBS new 52 week low

[AveragePenny]

Intelligent Bio Solutions Inc. (Nasdaq: $INBS ) Announces Major Steps Towards FDA Clearance and U.S. Launch.

https://thestreetreports.com/intelligent-bio-solutions-inc-nasdaq-inbs-announces-major-steps-towards-fda-clearance-and-u-s-launch/

In July 2024, Intelligent Bio Solutions Inc. (Nasdaq: INBS) revealed that three UK-based manufacturers adopted its Fingerprint Drug Screening System, renowned for its fast, intelligent, and non-invasive drug detection through fingertip sweat. This innovation’s biocompatibility has propelled it towards FDA clearance, with plans for a U.S. launch in 2025.

On August 1, Intelligent Bio Solutions entered a strategic partnership with CenExel, a nationwide clinical research site network operator. This collaboration is part of an FDA clinical study plan, involving a method comparison clinical study.

Under the study, 135 healthy adult subjects across three sites will participate in tests comparing the fingerprint sweat opiate screening results with those from the traceable LC-MS/MS method, the current gold standard.

This partnership and study are the final stages of Intelligent Bio Solutions’ clinical study plan. Over the past two months, the company has made significant progress and is on track to submit its 510(k) application to the FDA in Q4 2024. The company praised the efforts of its clinical study partners and team for their role in the smooth progression of this process.

Intelligent Bio Solutions Inc. is moving closer to revolutionizing drug screening with its innovative, non-invasive solutions.

Here are four healthcare companies under $10 demonstrating robust market trends, volume, and awareness:

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) – Focuses on therapies for central nervous system disorders.
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) – Specializes in cancer immunotherapy products.
Savara Inc. (NASDAQ: SVRA) – Develops therapies for rare respiratory diseases.
Eyenovia, Inc. (NASDAQ: EYEN) – Innovates in ophthalmic treatments.
These companies are actively involved in the healthcare sector, showcasing market strength through their innovative products and services.

[AveragePenny]

$INBS Intelligent Bio begins dosing for non-invasive drug screening technology


https://finance.yahoo.com/news/intelligent-bio-begins-dosing-non-103309318.html

US-based company Intelligent Bio Solutions has completed patient screening and will start dosing and sampling in the pharmacokinetic (PK) study for its fingerprint drug screening technology.

The study is expected to support the planned 510(k) submission to the US FDA, intended for Q4 of this year. Intelligent Bio expects the study to complete recruitment by the end of June, with a review of the PK study results expected to be finalised by the end of next month.

The news comes on the heels of last week’s announcement of the company’s decision to shift its “operating structure from a UK-based model to a global framework”. Intelligent Bio plans to enter the US market with its fingerprint drug screening technology during H1 next year.

The Intelligent fingerprinting drug screening system detects the presence of specific drugs and their metabolites using fingerprint sweat analysis. Using a small, tamper-evident drug screening cartridge, the device can collect ten fingerprint sweat samples in under a minute.

The device aims to identify “current impairment”, not past use, as the test has a detection window of approximately 14–16 hours. The test is intended to be used to check for “fitness for duty” on the day and screen for common drugs of abuse such as cocaine, cannabis, methamphetamine and opiates.

The PK study aims to investigate the levels of opiates in fingerprint sweat compared with blood, oral fluid and urine samples. It will recruit 40 healthy adults and analyse the specimens using validated methods such as liquid chromatography, mass spectrometry and the Intelligent fingerprinting drug screening system.

The use of sweat testing as a method of drug detection is being developed by multiple companies. In February, the US Anti-Doping Agency partnered with Epicore to develop a sweat-sensing technology as a method of drug detection.

Epicore’s wearable sweat-collection device, Discovery Patch, comprises a wearable microfluidic patch that captures eccrine sweat directly from the skin during exercise, environmental exposure and pharmacologic modes of sweat induction. Sweat is transferred from the microfluidic patch to clean lab storage containers using a sweat extraction apparatus designed to rapidly collect and prepare sweat samples for biochemical analysis.

"Intelligent Bio begins dosing for non-invasive drug screening technology" was originally created and published by Medical Device Network, a GlobalData owned brand.

[AveragePenny]

$INBS Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Conference on June 12-13, 2024

https://www.globenewswire.com/news-release/2024/06/06/2894659/0/en/Intelligent-Bio-Solutions-to-Participate-in-the-Sidoti-Small-Cap-Conference-on-June-12-13-2024.html

NEW YORK, June 06, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that its management team will participate in the Sidoti Small-Cap Conference being held virtually June 12-13, 2024.

Presentation Details
Date: Wednesday, June 12, 2024
Time: 4:00 p.m. Eastern Time
Registration/Webcast Link: https://sidoti.zoom.us/webinar/register/WN_BB5QumW3TK2N56X7MOPjpw

For more information about the conference, or to schedule a one-on-one meeting with the INBS management team, please contact your Sidoti representative or email KCSA Strategic Communications at [e-mail].

[AveragePenny]

$INBS - "management team will be presenting at the @SidotiResearch #SmallCap Conference at 4:00 pm ET on June 12, 2024.

Webcast Link: https://bit.ly/4bK8BQ7

For more info or to schedule a 1:1 with the INBS management team, please contact your Sidoti rep or email [e-mail]"

$INBS' management team will be presenting at the @SidotiResearch #SmallCap Conference at 4:00 pm ET on June 12, 2024.

Webcast Link: https://t.co/W1mGTRbh9v

For more info or to schedule a 1:1 with the INBS management team, please contact your Sidoti rep or email [e-mail] pic.twitter.com/wsusxthSeF

— Intelligent Bio Solutions (@ibs_inc_) June 6, 2024

[AveragePenny]

$INBS - "Conventional drug tests can be intrusive and uncomfortable for both test takers and administrators. Fingerprint drug tests provide a dignified, hygienic, and cost-effective alternative for businesses. Discover more:
https://ibs.inc/2024/05/06/fingerprint-drug-tests-compared-to-urine-and-saliva/?utm_content=292069159&utm_medium=social&utm_source=twitter&hss_channel=tw-1172043611963187200
"

Conventional drug tests can be intrusive and uncomfortable for both test takers and administrators. Fingerprint drug tests provide a dignified, hygienic, and cost-effective alternative for businesses. Discover more: https://t.co/N9UnhKEeXW

— Intelligent Bio Solutions (@ibs_inc_) May 6, 2024

[AveragePenny]

Stocks to Watch for Short Squeeze Potential: DJT, INBS, IMPP, HUBC, XXII

https://thestreetreports.com/stocks-to-watch-for-short-squeeze-potential-djt-inbs-impp-hubc-xxii/

Investors must stay alert to stocks poised for a short squeeze, given the significant gains typically seen during such events. Here’s a glimpse into five stocks potentially set for a short squeeze surge in the future.

Trump Media & Technology Corp. (NASDAQ: DJT) witnessed a stellar debut last week, followed by a more subdued performance. The short interest in DJT stock, reflecting borrowed shares anticipating a price drop, hit 4.93 million, representing 12.6% of available shares. Notably, the borrowing rate spiked to 500% due to limited shortable shares, hinting at potential short covering and a share price uptick in the future.

Intelligent Bio Solutions Inc. (NASDAQ: INBS) is attracting attention this week for potential short squeeze dynamics. As a leading provider of innovative medical tech, it posted impressive financials for Q2 and the six months ending Dec 31, 2023, with a 114% revenue increase YoY for Q2 and 337% for the six months. This growth is tied to its Intelligent Fingerprinting Drug Screening System and global expansion. The stock hit an intraday high of $11.70 and closing high of $6.76 in 2024. This low-float stock is currently oversold, and the short interest in INBS stock surged to 57.64% in the latest report is adding intrigue to INBS’s stock movement.

Imperial Petroleum Inc. (NASDAQ: IMPP) is worth monitoring due to its significant short interest. On February 13, IMPP announced its financial results for the fourth quarter and fiscal year ending December 31, 2023. The company’s revenues for the quarter were $29.9 million, down from $37.9 million in the previous year, while net income decreased from $13.8 million to $6.5 million. However, for the full fiscal year, revenues rose by $86.7 million to reach $183.7 million compared to the previous year.

HUB Cyber Security Ltd. (NASDAQ: HUBC) is a potential stock to watch this week, given its focus on confidential computer cyber security solutions and services. On April 5, HUBC made headlines by securing $8 million in new financing through a straight debt arrangement. This strategic financing is aimed at bolstering the company’s financial position and enhancing its future prospects, as stated in the news release.

22nd Century Group Inc. (NASDAQ: XXII), a company focused on reducing nicotine harm in tobacco products, disclosed its financial performance for the quarter ending December 31, 2023, on March 28. The company reported a decrease in net revenues from $10 million to $7.4 million compared to the prior-year period. The operating loss widened from $10.2 million to $14.2 million year-over-year. Despite this, the gross profit surged from $0.1 million to $7.8 million in the same period.

[AveragePenny]

$INBS Intelligent Bio Solutions to Present at the LD Micro Invitational XIV Investor Conference on April 9 in NYC

https://www.globenewswire.com/news-release/2024/03/26/2852359/0/en/Intelligent-Bio-Solutions-to-Present-at-the-LD-Micro-Invitational-XIV-Investor-Conference-on-April-9-in-NYC.html

[AveragePenny]

$INBS - Ladenburg Research Report: FDA Submission on Track for Submission in Q4-24; OUS Revenue Continues to Grow

https://ladenburg.bluematrix.com/sellside/EmailDocViewer?encrypt=2cbd38db-9256-42ca-b38c-9b7a3e678904&mime=pdf&co=Ladenburg&id=[e-mail]&source=mail